PuSH - Publication Server of Helmholtz Zentrum München

144 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Bediaga, N.G.* et al.: Cytotoxicity-related gene expression and chromatin accessibility define a subset of CD4+ T cells that mark progression to type 1 diabetes. Diabetes 71, 566-577 (2022)
2.
Scarale, M.G.* et al.: Circulating metabolites associate with and improve the prediction of all-cause mortality in type 2 diabetes. Diabetes, DOI: 10.2337/db22-0095 (2022)
3.
Sims, E.K.* et al.: Screening for type 1 diabetes in the general population: A status report and perspective. Diabetes 71, 610-623 (2022)
4.
Baboota, R.K.* ; Blüher, M. & Smith, U.*: Emerging role of bone morphogenetic protein 4 in metabolic disorders. Diabetes 70, 303-312 (2021)
5.
Chen, J.* et al.: CaM kinase II-δ is required for diabetic hyperglycemia and retinopathy but not nephropathy. Diabetes 70, 616-626 (2021)
6.
Eriksson, O.* et al.: Drug occupancy assessment at the glucose-dependent insulinotropic polypeptide (GIP) receptor by positron emission tomography. Diabetes 70, 842-853 (2021)
7.
Fritsche, A. et al.: Different effects of lifestyle intervention in high- and low-risk prediabetes. Diabetes 70, 2785-2795:2785-2795 (2021)
8.
Herder, C.* et al.: Differences in biomarkers of inflammation between novel subgroups of recent-onset diabetes. Diabetes 70, 1198-1208 (2021)
9.
Li, Q.* et al.: Plasma metabolome and circulating vitamins stratified onset age of an initial islet autoantibody and progression to type 1 diabetes: The TEDDY Study. Diabetes 70, 282-292 (2021)
10.
Lundsgaard, A.M.* et al.: Small amounts of dietary medium-chain fatty acids protect against insulin resistance during caloric excess in humans. Diabetes 70, 91-98 (2021)
11.
Rodriguez-Calvo, T. et al.: Altered β-cell prohormone processing and secretion in type 1 diabetes. Diabetes 70, 1038-1050 (2021)
12.
Rodriguez-Calvo, T. ; Krogvold, L.* ; Amirian, N.* ; Dahl-Jørgensen, K.* & von Herrath, M.*: One in ten CD8+ cells in the pancreas of living individuals with recent onset type 1 diabetes recognizes the preproinsulin epitope PPI15-24. Diabetes 70, 752-758 (2021)
13.
Tura, A.* et al.: Profiles of glucose metabolism in different prediabetes phenotypes, classified by fasting glycemia, 2-hour OGTT, glycated hemoglobin, and 1-hour OGTT: An IMI DIRECT study. Diabetes 70, 2092-2106 (2021)
14.
Buitinga, M.* et al.: Non-invasive monitoring of glycemia-induced regulation of GLP-1R expression in murine and human islets of Langerhans. Diabetes 69, 2246-2252 (2020)
15.
Elhadad, M.A. et al.: Deciphering the plasma proteome of type 2 diabetes. Diabetes 69, 2766-2778 (2020)
16.
Huang, J. et al.: Machine learning approaches reveal metabolic signatures of incident chronic kidney disease in individuals with prediabetes and type 2 diabetes. Diabetes 69, 2756-2765 (2020)
17.
Jende, J.M.E.* et al.: Troponin T parallels structural nerve damage in type 2 diabetes: A cross-sectional study using magnetic resonance neurography. Diabetes 69, 713-723 (2020)
18.
Kleinert, M. & Müller, T.D.: A new FGF21 analog for the treatment of fatty liver disease. Diabetes 69, 1605-1607 (2020)
19.
Knoop, J. et al.: Maternal type 1 diabetes reduces autoantigen-responsive CD4(+) T cells in Offspring. Diabetes 69, 661-669 (2020)
20.
Li, Q.* et al.: Longitudinal metabolome-wide signals prior to the appearance of a first islet autoantibody in children participating in the TEDDY Study. Diabetes 69, 465-476 (2020)